DPYD genotype-guided dose personalisation for fluoropyrimidine-based chemotherapy prescribing in solid organ cancer patients in Australia: GeneScreen 5-FU study protocol.
White C, Wardill H, Paul C, Price T, Karapetis C, Nalder M, Burge ME, Thomas A, Oldmeadow C, Barker D, Edney LC, Coller J, Bowen J, Ostroff C, Cheek B, Carlson M, Rankmore T, Nagrial A, Clarke S, Chantrill L, Ackland S, Scott RJ.
White C, et al. Among authors: edney lc.
BMC Cancer. 2024 Nov 8;24(1):1369. doi: 10.1186/s12885-024-13122-8.
BMC Cancer. 2024.
PMID: 39516829